Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

Imaging Cognition II: An Empirical Review of 275 PET and fMRI Studies

2000 • 3,607 citations

Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers

2001 • 967 citations

Neuropsychological Performance in Long-term Cannabis Users

2001 • 649 citations

Memory impairment in abstinent MDMA ("Ecstasy") users

1998 • 381 citations

Altered Serotonin Innervation Patterns in the Forebrain of Monkeys Treated with (±)3,4-Methylenedioxymethamphetamine Seven Years Previously: Factors Influencing Abnormal Recovery

1999 • 340 citations

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

2000 • 309 citations

Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

1999 • 305 citations

Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine

2002 • 304 citations

Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1

2002 • 297 citations

Memory deficits associated with recreational use of "ecstasy" (MDMA)

1999 • 287 citations

Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients

2002 • 201 citations

Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy")

2001 • 196 citations

(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies

2000 • 193 citations

RETRACTED: Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy")

2002 • 179 citations

Neuroprotection by Δ⁹-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-InducedIn VivoExcitotoxicity

2001 • 176 citations

Dexanabinol (HU-211) in the treatment of severe closed head injury: A randomized, placebo-controlled, phase II clinical trial*

2002 • 159 citations

Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or ‘ecstasy’: evidence for cognitive impairment

2001 • 137 citations

A study of the mechanisms involved in the neurotoxic action of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain

2001 • 125 citations

No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study

2001 • 84 citations

Effect of 3,4-methylenedioxymethamphetamine ("ecstasy") on body temperature and liver antioxidant status in mice: influence of ambient temperature

2002 • 71 citations

Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]β-CIT SPECT study – preliminary report

2001 • 71 citations

Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study

2003 • 66 citations

Protection against 3,4‐methylenedioxymethamphetamine‐induced neurodegeneration produced by glutathione depletion in rats is mediated by attenuation of hyperthermia

2002 • 19 citations

Attentional Processes in Abstinent Methylenedioxymethamphetamine (Ecstasy) Users

2002 • 17 citations